Olaru ID - Search Results

1

Knowledge, attitudes and practices relating to antibiotic use and resistance among prescribers from public primary healthcare facilities in Harare, Zimbabwe.

Olaru ID, Ferrand RA, Yeung S, Chingono R, Chonzi P, Masunda KPE, Dixon J, Kranzer K. Olaru ID, et al. Wellcome Open Res. 2022 Apr 29;6:72. doi: 10.12688/wellcomeopenres.16657.2. eCollection 2021. Wellcome Open Res. 2022. PMID: 37780956 Free PMC article.

2

Pathogen-free diagnosis of tuberculosis.

Heyckendorf J, Reimann M, Marwitz S, Lange C; DZIF-TB cohort study group. Heyckendorf J, et al. Lancet Infect Dis. 2021 Aug;21(8):1066. doi: 10.1016/S1473-3099(21)00337-6. Lancet Infect Dis. 2021. PMID: 34331877 No abstract available.

3

Novel drugs against tuberculosis: a clinician's perspective.

Olaru ID, von Groote-Bidlingmaier F, Heyckendorf J, Yew WW, Lange C, Chang KC. Olaru ID, et al. Eur Respir J. 2015 Apr;45(4):1119-31. doi: 10.1183/09031936.00162314. Epub 2014 Nov 27. Eur Respir J. 2015. PMID: 25431273 Free article. Review.

4

Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany.

Gutsfeld C, Olaru ID, Vollrath O, Lange C. Gutsfeld C, et al. Among authors: olaru id. PLoS One. 2014 Nov 13;9(11):e112681. doi: 10.1371/journal.pone.0112681. eCollection 2014. PLoS One. 2014. PMID: 25393241 Free PMC article.

5

Ascertaining in vivo virulence of Mycobacterium tuberculosis lineages in patients in Mbeya, Tanzania.

Olaru ID, Rachow A, Lange C, Ntinginya NE, Reither K, Hoelscher M, Vollrath O, Niemann S. Olaru ID, et al. Int J Tuberc Lung Dis. 2015 Jan;19(1):70-3. doi: 10.5588/ijtld.14.0403. Int J Tuberc Lung Dis. 2015. PMID: 25519793

6

Time to culture positivity and sputum smear microscopy during tuberculosis therapy.

Olaru ID, Heyckendorf J, Grossmann S, Lange C. Olaru ID, et al. PLoS One. 2014 Aug 29;9(8):e106075. doi: 10.1371/journal.pone.0106075. eCollection 2014. PLoS One. 2014. PMID: 25171337 Free PMC article.

7

[Tuberculosis].

Kalsdorf B, Olaru ID, Lange C, Heyckendorf J. Kalsdorf B, et al. Among authors: olaru id. Dtsch Med Wochenschr. 2015 Oct;140(20):1508-12. doi: 10.1055/s-0041-105904. Epub 2015 Oct 7. Dtsch Med Wochenschr. 2015. PMID: 26445253 Review. German.

8

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

van Leth F, Günther G, Hoffmann H, Lange C; European MDR-TB Database Collaboration. van Leth F, et al. Am J Respir Crit Care Med. 2017 Dec 1;196(11):1489-1490. doi: 10.1164/rccm.201705-0995LE. Am J Respir Crit Care Med. 2017. PMID: 28715229 No abstract available.

9

Language discordance between tuberculosis patients and healthcare providers challenging universal access.

Nakiwala D, Kellgren L, Herzmann C, Olaru ID, Brown M, Ferrand R, Khan P, Kranzer K. Nakiwala D, et al. Among authors: olaru id. Eur Respir J. 2017 Apr 19;49(4):1700116. doi: 10.1183/13993003.00116-2017. Print 2017 Apr. Eur Respir J. 2017. PMID: 28424365 Free article. No abstract available.

10

False-negative HIV tests using oral fluid tests in children taking antiretroviral therapy from Harare, Zimbabwe.

Olaru ID, McHugh G, Dakshina S, Majonga E, Dauya E, Bandason T, Kranzer K, Mujuru H, Ferrand RA. Olaru ID, et al. J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21751. doi: 10.7448/IAS.20.7.21751. J Int AIDS Soc. 2017. PMID: 28872275 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters